Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

Hair loss treatments work better with lifestyle changes.

The formulation significantly increased hair density and thickness safely in people with androgenetic alopecia.

Men with androgenetic alopecia may have more sexual dysfunctions.

Different hair loss types need accurate diagnosis for proper treatment.

Ac-GFFY-IGF peptide is a promising, safe, and effective treatment for hair loss, better than current options.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Targeting multiple pathways may improve treatments for androgenetic alopecia.

Men with severe androgenetic alopecia, especially on the top of the head, have a higher risk of coronary artery disease.

Androgenetic alopecia, or hair loss, is caused by genetic factors and hormones, with different mechanisms in men and women, and can be linked to insulin resistance and polycystic ovary syndrome.

Korean adolescents with androgenetic alopecia often have a family history, milder symptoms than adults, and normal hormone levels.

Female and male AGA are different diseases.

A 6-year-old girl had a rare allergic reaction to a hair regrowth treatment.

Gasdermin A3 overexpression in skin causes inflammation and hair loss.

A Gsdma3 mutation causes hair loss due to stem cell damage from skin inflammation.

AGA linked to worse COVID-19 outcomes in men.

Adenosine helps grow thicker hair in Japanese men with hair loss.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

Inflammation damages sweat ducts, causing sweat gland injury.

Untreated androgenetic alopecia leads to progressive hair loss in men.

Androgenetic alopecia is a condition causing noticeable hair loss, especially in middle age, which is more severe than normal balding.

People with moderate or severe hair loss have higher death rates from diabetes and heart disease.

Autologous growth factor concentrate therapy shows promise for treating early-stage hair loss safely and effectively.

Adolescents with hair loss show different hormone levels by sex and often have related metabolic issues.

Hair thickness differences help diagnose hair loss severity.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

Higher aldosterone levels link to hair loss and high blood pressure.

Agouti and AGRP affect pigmentation and obesity, with implications for metabolic disorders.

GLP-1 receptor agonists may increase the risk of a specific type of hair loss called androgenetic alopecia.